Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

50%(2 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_2

20%

Ph not_applicable

60%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (20.0%)

Phase 41 (20.0%)

N/A3 (60.0%)

Trials by Status

completed480%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_4

Clinical Trials (5)

Showing 5 of 5 trials

NCT03365362Phase 4

A Trial of Directly Observed and Long-term Varenicline

Completed

NCT02573376Not Applicable

Antiviral Pharmacology and Adherence in Drug Users

Completed

NCT05022706Not Applicable

Pilot Study of a Transition Intervention for ALWH

Completed

NCT02206061Not Applicable

School-based Asthma Care for Teens (SB-ACT)

Completed

NCT00076804Phase 2

Helping HIV Infected Patients in South Africa Adhere to Drug Regimens

Terminated

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5